How much funding has EpiCept raised?

EpiCept has raised $2.0M in total funding, most recently a Series A round.

Where is EpiCept headquartered?

EpiCept is headquartered in Tarrytown, United States.

What industry is EpiCept in?

EpiCept operates in Healthcare, Pharmaceuticals, Biotech, Oncology.

EpiCept

epicept.com

Tarrytown, United States · Founded 1999 · $2.0M raised

Headquarters: Tarrytown
Employees: 11–50
Founded: 1999
Business Model: B2B

Website: epicept.com
Total Funding: $2.0M
Last Round: $2.0M Series AFeb 2012
Rounds: 1

About

EpiCept Corporation was a specialty pharmaceutical company focused on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company's pipeline included Ceplene (histamine dihydrochloride), approved in the European Union in 2008 for treatment of acute myeloid leukemia, and Azixa, an oncology candidate. EpiCept merged with Immune Pharmaceuticals in 2013 and subsequently ceased independent operations. Headquartered in Tarrytown, New York.

Summary

EpiCept is a Healthcare company based in Tarrytown, United States, founded in 1999. It has raised $2.0M in total across 1 round, most recently a $2.0M Series A round in Feb 2012.